Different Administration Strategies With Paclitaxel Induce Distinct Phenotypes of Multidrug Resistance in Breast Cancer Cells

Cancer Letters - Ireland
doi 10.1016/j.canlet.2013.02.059
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

Enriched Variations in TEKT4 and Breast Cancer Resistance to Paclitaxel

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Paclitaxel in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Screening of Deoxyribozyme With High Reversal Efficiency Against Multidrug Resistance in Breast Carcinoma Cells

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2011English

Co-Suppression of MDR1 (Multidrug Resistance 1) and GCS（glucosylceramide Synthase）restores Sensitivity to Multidrug Resistance Breast Cancer Cells by RNA Interference (RNAi)

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Epstein-Barr Virus (EBV) Genome and Expression in Breast Cancer Tissue: Effect of EBV Infection of Breast Cancer Cells on Resistance to Paclitaxel (Taxol)

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

Indomethacin-Based Stimuli-Responsive Micelles Combined With Paclitaxel to Overcome Multidrug Resistance

Oncotarget
Oncology
2017English

Breast Cancer Stem Cells in Antiestrogen Resistance

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy